Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
Uro-Oncology
Related content
Uro-Oncology
Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement
BJU Int.
Tandogdu Z, Collins J, Shaw G, Rohn J, Koves B, Sachdeva A, Ghazi A, Haese A, Mottrie A, Kumar A, Sivaraman A, Tewari A, Challacombe B, Rocco B, Giedelman C, Wagner C, Rogers CG, Murphy DG, Pushkar D, Ogaya-Pinies G, Porter J, Ramesh Seetharam K, Graefen M, Orvieto MA, Covas Moschovas M, Schatloff O, Wiklund P, Coelho R, Valero R, de Reijke TM, Ahlering T, Rogers T, van der Poel HG, Patel V, Artibani W, Wagenlehner F, Nathan S, Erik Bjerklund Johansens T, Hawkey P, Kelly J
doi: 10.1111/bju.15299.
Menopause
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
Menopause.
Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA
doi: 10.1097/GME.
HPV and Gynecologic Cancer
Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer
Am J Obstet Gynecol.
Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ, Kolev V, Prasad-Hayes M, Cohen S, Holcomb K, Blank SV
doi: 10.1016/j.ajog.2020.06.049.
Reproductive Health
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
BMC Med.
Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS
doi: 10.1186/s12916-020-01697-5.
Further Publications UrologyFurther Publications Gynecology
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
Eur Urol.
Novara G, Checcucci E, Crestani A, Abrate A, Esperto F, Pavan N, De Nunzio C, Galfano A, Giannarini G, Gregori A, Liguori G, Bartoletti R, Porpiglia F, Scarpa RM, Simonato A, Trombetta C, Tubaro A, Ficarra V, Research Urology Network (RUN).
doi: 10.1016/j.eururo.2020.06.025.
Uro-Oncology
Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
Eur Urol.
Louis L, Thomas S, Yohann L, Morgan R
doi: 10.1016/j.eururo.2020.04.039.
COMMENTED
Uro-Oncology
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
doi: 10.1016/j.eururo.2020.01.033.
Further Publications UrologyFurther Publications Gynecology
VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic
No abstract available
Further Publications UrologyFurther Publications Gynecology
COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics
doi: 10.1016/j.ajog.2020.03.038.